{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:14:22Z","timestamp":1791951262039,"version":"4.3.4"},"reference-count":46,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Pulmonary hypertension (PH) is a rare progressive and lethal disease affecting pulmonary arteries and heart function. The disease may compromise the nutritional status of the patient, which impairs their physical performance. This study aimed to determine the prevalence of micronutrient deficiencies in pulmonary arterial hypertension (PAH) and chronic thrombo-embolic pulmonary hypertension (CTEPH) patients. Methods: Eighty-one blood samples from a prospective observational cohort study were analyzed for concentrations of micronutrients and inflammation-related factors. The samples consisted of newly diagnosed (treatment-naive) PAH and CTEPH patients and patients treated for 1.5 years according to ERS\/ESC guidelines. Results: In the newly diagnosed group, 42% of PAH patients and 21% of CTEPH patients were iron deficient compared to 29% of PAH patients and 20% of CTEPH patients in the treatment group. Vitamin D deficiency occurred in 42% of the newly diagnosed PAH patients, 71% of the newly diagnosed CTEPH patients, 68% of the treated PAH patients, and 70% of the treated CTEPH patients. Iron levels correlated with the 6 min walking distance (6MWD). Conclusions: Iron and vitamin D deficiencies are highly prevalent in PAH and CTEPH patients, underlining the need for monitoring their status. Studies evaluating the effects of supplementation strategies for iron and vitamin D are necessary.<\/jats:p>","DOI":"10.3390\/nu13113923","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T22:24:22Z","timestamp":1635805462000},"page":"3923","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6657-8065","authenticated-orcid":false,"given":"Paulien","family":"Vinke","sequence":"first","affiliation":[{"name":"Nutritional Biology, Division of Human Nutrition and Health, Wageningen University, Stippeneng 4, 6708 WE Wageningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Koudstaal","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Muskens","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemien","family":"van den Bosch","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Balvers","sequence":"additional","affiliation":[{"name":"Nutritional Biology, Division of Human Nutrition and Health, Wageningen University, Stippeneng 4, 6708 WE Wageningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Poland","sequence":"additional","affiliation":[{"name":"Nutritional Biology, Division of Human Nutrition and Health, Wageningen University, Stippeneng 4, 6708 WE Wageningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7935-8261","authenticated-orcid":false,"given":"Renger F.","family":"Witkamp","sequence":"additional","affiliation":[{"name":"Nutritional Biology, Division of Human Nutrition and Health, Wageningen University, Stippeneng 4, 6708 WE Wageningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6281-9455","authenticated-orcid":false,"given":"Klaske","family":"van Norren","sequence":"additional","affiliation":[{"name":"Nutritional Biology, Division of Human Nutrition and Health, Wageningen University, Stippeneng 4, 6708 WE Wageningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1519-8147","authenticated-orcid":false,"given":"Karin A.","family":"Boomars","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10741-018-9717-9","article-title":"Increasing quality of life in pulmonary arterial hypertension: Is there a role for nutrition?","volume":"23","author":"Vinke","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/resp.13141","article-title":"Pathophysiology of exercise intolerance in pulmonary arterial hypertension","volume":"23","author":"Tran","year":"2018","journal-title":"Respirology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Heukels, P., Corneth, O.B.J., Van Uden, D., Van Hulst, J.A.C., Van Den Toorn, L.M., Van Den Bosch, A.E., Wijsenbeek, M.S., Boomars, K.A., Kool, M., and Hendriks, R.W. (2021). Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension. Thorax, Online ahead of print.","DOI":"10.1136\/thoraxjnl-2020-215460"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: State of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1183\/09031936.00009914","article-title":"Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension","volume":"46","author":"Quarck","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"160112","DOI":"10.1183\/16000617.0112-2016","article-title":"The pathophysiology of chronic thromboembolic pulmonary hypertension","volume":"26","author":"Simonneau","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"106934","DOI":"10.1016\/j.intimp.2020.106934","article-title":"The role of macrophages in pulmonary hypertension: Pathogenesis and targeting","volume":"88","author":"Chen","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"van Uden, D., Koudstaal, T., van Hulst, J.A.C., Bergen, I.M., Gootjes, C., Morrell, N.W., van Loo, G., von der Th\u00fcsen, J.H., van den Bosch, T.P.P., and Ghigna, M.R. (2021). Central role of dendritic cells in pulmonary arterial hypertension in human and mice. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041756"},{"key":"ref_11","first-page":"903","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"46","author":"Humbert","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the reveal registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/14017431.2016.1185532","article-title":"Characteristics and survival of adult Swedish PAH and CTEPH patients 2000\u20132014","volume":"50","author":"Ekmehag","year":"2016","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1800589","DOI":"10.1183\/13993003.00589-2018","article-title":"The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension","volume":"52","author":"Quadery","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1700889","DOI":"10.1183\/13993003.00889-2017","article-title":"Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/14017431.2020.1783456","article-title":"Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival","volume":"55","author":"Sandqvist","year":"2021","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jamda.2017.05.026","article-title":"Minerals and Sarcopenia; The Role of Calcium, Iron, Magnesium, Phosphorus, Potassium, Selenium, Sodium, and Zinc on Muscle Mass, Muscle Strength, and Physical Performance in Older Adults: A Systematic Review","volume":"19","author":"Abdelrazek","year":"2018","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1079\/BJN2003837","article-title":"Vitamin D in preventive medicine: Are we ignoring the evidence?","volume":"89","author":"Zittermann","year":"2003","journal-title":"Br. J. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/thx.2010.147272","article-title":"Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension","volume":"66","author":"Soon","year":"2011","journal-title":"Thorax"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1183\/09031936.00100510","article-title":"Iron deficiency is common in idiopathic pulmonary arterial hypertension","volume":"37","author":"Ruiter","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00012.2014","article-title":"Magnesium in man: Implications for health and disease","volume":"95","author":"Hoenderop","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/ajcn\/84.2.419","article-title":"Magnesium and muscle performance in older persons: The InCHIANTI study","volume":"84","author":"Dominguez","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10787-019-00603-7","article-title":"The role of magnesium in different inflammatory diseases","volume":"27","author":"Shahi","year":"2019","journal-title":"Inflammopharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jclinpath-2012-201301","article-title":"Vitamin D: A negative acute phase reactant","volume":"66","author":"Waldron","year":"2013","journal-title":"J. Clin. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1017\/jns.2015.10","article-title":"Recommended intakes of Vitamin D to optimise health, associated circulating 25-hydroxyVitamin D concentrations, and dosing regimens to treat deficiency: Workshop report and overview of current literature","volume":"4","author":"Balvers","year":"2015","journal-title":"J. Nutr. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clnesp.2018.12.087","article-title":"Towards improved pharmacotherapy in pulmonary arterial hypertension. Can diet play a role?","volume":"30","author":"Semen","year":"2019","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2045894019885364","DOI":"10.1177\/2045894019885364","article-title":"Nocturnal hypoxia in patients with idiopathic pulmonary arterial hypertension","volume":"10","author":"Yan","year":"2020","journal-title":"Pulm. Circ."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1183\/09031936.00112408","article-title":"Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients","volume":"33","author":"Godoy","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1038\/s41598-018-33471-2","article-title":"Molecular signalling towards mitochondrial breakdown is enhanced in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD)","volume":"8","author":"Leermakers","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/682217","article-title":"Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency","volume":"5","author":"Ruiter","year":"2015","journal-title":"Pulm. Circ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1183\/09031936.00037711","article-title":"Iron deficiency in pulmonary arterial hypertension: A potential therapeutic target","volume":"38","author":"Rhodes","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fphys.2018.00641","article-title":"Pulmonary arterial hypertension: Iron matters","volume":"9","author":"Ramakrishnan","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"10275","DOI":"10.1074\/jbc.M116.770974","article-title":"Interleukin-1\u03b2 (IL-1\u03b2) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein \u03b4 (C\/EBP\u03b4) expression in hepatocytes","volume":"292","author":"Kanamori","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: Pathogenesis and Clinical Significance","volume":"43","author":"Soeters","year":"2019","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2000616","DOI":"10.1183\/13993003.00616-2020","article-title":"Oral iron supplementation with ferric maltol in patients with pulmonary hypertension","volume":"56","author":"Olsson","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sassi, F., Tamone, C., and D\u2019amelio, P. (2018). Vitamin D: Nutrient, hormone, and immunomodulator. Nutrients, 10.","DOI":"10.3390\/nu10111656"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s41430-020-0558-y","article-title":"Vitamin D deficiency 2.0: An update on the current status worldwide","volume":"74","author":"Amrein","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3945\/ajcn.115.120873","article-title":"Vitamin D deficiency in Europe: Pandemic?","volume":"103","author":"Cashman","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41430-018-0353-1","article-title":"Factors associated with serum 25-hydroxyvitamin D concentrations in older people in Europe: The EUREYE study","volume":"73","author":"Casey","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s00394-018-1856-1","article-title":"Determinants of vitamin D status in physically active elderly in the Netherlands","volume":"58","author":"Balvers","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ajcn\/85.3.755","article-title":"Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: The Hoorn Study","volume":"85","author":"Snijder","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Sousa-Santos, A.R., Afonso, C., Santos, A., Borges, N., Moreira, P., Padr\u00e3o, P., Fonseca, I., and Amaral, T.F. (2018). The association between 25(OH)D levels, frailty status and obesity indices in older adults. PLoS ONE, 13.","DOI":"10.1101\/330340"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2012-4103","article-title":"25-Hydroxyvitamin D response to graded vitamin D3 supplementation among obese adults","volume":"98","author":"Drincic","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","first-page":"253","article-title":"Benefits from the correction of vitamin D deficiency in patients with pulmonary hypertension","volume":"7","author":"Mirdamadi","year":"2016","journal-title":"Casp. J. Intern. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Tanaka, H., Kataoka, M., Isobe, S., Yamamoto, T., Shirakawa, K., Endo, J., Satoh, T., Hakamata, Y., Kobayashi, E., and Sano, M. (2017). Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180615"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/11\/3923\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:24:30Z","timestamp":1760167470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/11\/3923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["nu13113923"],"URL":"https:\/\/doi.org\/10.3390\/nu13113923","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}